- Corporate Officers - G
- Gergel Ivan
Insider Trading History of Gergel Ivan
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gergel Ivan since 2007.
The trader's CIK number is 1328288.
At the time of the last reporting, Gergel Ivan was the SVP Scientific Affai of Nektar Therapeutics. (stock ticker symbol NKTR).
Also see all insider trading activities at Nektar Therapeutics.
Note that in the past
Gergel Ivan also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Forest Laboratories Inc (FRX) by Gergel Ivan
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | FRX | 0 | $0 | 32,250 | $1,723,859 | 32,250 | $1,253,557 |
Yearly summary of insider trading at Endo Pharmaceuticals Holdings Inc (ENDP) by Gergel Ivan
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | ENDP | 0 | $0 | 138,225 | $5,039,268 | 138,461 | $2,298,717 |
| 2011 | ENDP | 0 | $0 | 58,845 | $2,115,817 | 85,477 | $1,247,109 |
| 2010 | ENDP | 0 | $0 | 55,603 | $2,031,177 | 55,603 | $1,249,677 |
Yearly summary of insider trading at Endo International Plc (ENDP) by Gergel Ivan
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | ENDP | 0 | $0 | 75,637 | $5,481,413 | 75,637 | $2,270,774 |
Yearly summary of insider trading at Nektar Therapeutics (NKTR) by Gergel Ivan
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NKTR | 0 | $0 | 204,904 | $4,608,840 | 200,000 | $2,207,997 |
| 2016 | NKTR | 0 | $0 | 3,521 | $53,919 | 2,500 | $0 |
Insider trading activities at 4 companies by Gergel Ivan:
1. Forest Laboratories Inc (FRX)
2. Endo Pharmaceuticals Holdings Inc (ENDP)
3. Endo International Plc (ENDP)
4. Nektar Therapeutics (NKTR)
Table 1. Insider trading of Forest Laboratories Inc (FRX) by Gergel Ivan
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-02-14 | FRX | Option Ex | 32,250 | 38.87 | 1,253,557 |
| 2007-02-14 | FRX | Sale | 32,250 | 53.45 | 1,723,859 |
Table 2. Insider trading of Endo Pharmaceuticals Holdings Inc (ENDP) by Gergel Ivan
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-04-24 | ENDP | Option Ex | 105,190 | 21.85 | 2,298,717 |
| 2013-04-24 | ENDP | Sale | 138,225 | 36.46 | 5,039,268 |
| 2012-12-31 | ENDP | Option Ex | 33,271 | .00 | 0 |
| 2011-05-03 | ENDP | Option Ex | 12,500 | 25.02 | 312,750 |
| 2011-05-03 | ENDP | Sale | 12,500 | 39.39 | 492,375 |
| 2011-02-28 | ENDP | Option Ex | 30,603 | 19.93 | 609,917 |
| 2011-03-02 | ENDP | Sale | 30,603 | 35.77 | 1,094,669 |
| 2011-02-23 | ENDP | Option Ex | 26,632 | .00 | 0 |
| 2011-02-24 | ENDP | Option Ex | 15,742 | 20.61 | 324,442 |
| 2011-02-24 | ENDP | Sale | 15,742 | 33.59 | 528,773 |
| 2010-12-03 | ENDP | Option Ex | 55,603 | 22.48 | 1,249,677 |
| 2010-12-03 | ENDP | Sale | 55,603 | 36.53 | 2,031,177 |
Table 3. Insider trading of Endo International Plc (ENDP) by Gergel Ivan
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-03-10 | ENDP | Sale | 75,637 | 72.47 | 5,481,413 |
| 2014-03-10 | ENDP | Option Ex | 75,637 | 30.02 | 2,270,774 |
Table 4. Insider trading of Nektar Therapeutics (NKTR) by Gergel Ivan
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-10-02 | NKTR | Option Ex | 56,704 | 11.04 | 626,012 |
| 2017-10-02 | NKTR | Sale | 56,704 | 24.21 | 1,372,803 |
| 2017-09-29 | NKTR | Option Ex | 43,296 | 11.04 | 477,987 |
| 2017-09-29 | NKTR | Sale | 43,296 | 24.04 | 1,040,835 |
| 2017-08-16 | NKTR | Sale | 1,997 | 19.32 | 38,582 |
| 2017-07-18 | NKTR | Option Ex | 54,920 | 11.04 | 606,316 |
| 2017-07-18 | NKTR | Sale | 54,920 | 21.10 | 1,158,812 |
| 2017-07-12 | NKTR | Sale | 36,691 | 21.09 | 773,813 |
| 2017-07-11 | NKTR | Sale | 8,389 | 21.04 | 176,504 |
| 2017-07-12 | NKTR | Option Ex | 36,691 | 11.04 | 405,068 |
| 2017-07-11 | NKTR | Option Ex | 8,389 | 11.04 | 92,614 |
| 2017-05-16 | NKTR | Sale | 1,450 | 19.55 | 28,347 |
| 2017-02-16 | NKTR | Sale | 1,457 | 13.14 | 19,144 |
| 2016-11-16 | NKTR | Sale | 848 | 13.96 | 11,838 |
| 2016-08-16 | NKTR | Sale | 1,685 | 17.56 | 29,588 |
| 2016-05-16 | NKTR | Option Ex | 1,250 | .00 | 0 |
| 2016-05-17 | NKTR | Sale | 432 | 13.58 | 5,866 |
| 2016-02-16 | NKTR | Option Ex | 1,250 | .00 | 0 |
| 2016-02-17 | NKTR | Sale | 556 | 11.92 | 6,627 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gergel Ivan
(SVP Scientific Affai of Nektar Therapeutics at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.